Table 2.
Intervention | Annual visits (n) | Medications/year | Lab tests/year | Total cost/year |
---|---|---|---|---|
Aspirin to high-risk patients | 1 @ $74 | $17 | NA | $91 |
Lower LDL cholesterol to <160 mg/dl in low-risk individuals | 1 @ $74 | Branded statin @ $1,082 | Creatinine, ALT, lipid panel @ $125 | $1,281 |
Lower LDL cholesterol to <130 mg/dl in high-risk individuals | 2 @ $74 | Branded statin @ $1,543 | Creatinine, ALT, lipid panel @ $125 | $1,816 |
Lower LDL cholesterol to <100 mg/dl in people with CAD | 3 @ $74 | Branded statin @ $1,543 | Creatinine, ALT, lipid panel @ $125 × 3 | $2,140 |
Lower blood pressure in nondiabetic individuals | 4 @ $74 | Angiotensin inhibitor @ $1,238 | K+, creatinine, BUN @ $48 | $1,582 |
A1C control in diabetic individuals | 4 @ $74 | Generic and branded glucose lowering agents @ $3,150 | A1C @ $59 × 2 | $3,564 |
Lower blood pressure in diabetic individuals | 4 @ $74 | Angiotensin inhibitor and generic thiazide @ $1,238 | K+, creatinine, BUN @ $48 | $1,582 |
Lower LDL in diabetic individuals | 3 @ $74 | Branded statin @ $1,543 | Creatinine, ALT, lipid panel @ $125 × 3 | $2,140 |
Reduce fasting glucose <110 mg/dl | 2 @ $74 | Generic glucose-lowering agent @ $524 | Creatinine, ALT, BUN @ $60 | $732 |
Smoking cessation | 1 @ $80 | Patch and a drug @ $270 | NA | $350 |
Weight reduction (cost derived from ref. 44) | $1,356 in year 1, $672 annually thereafter | NA | NA | $1,356 year 1, $672 year 2+ |
BUN, blood urea nitrogen.